StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright increased their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Read Our Latest Stock Analysis on SenesTech
SenesTech Stock Up 2.3 %
SenesTech (NASDAQ:SNES – Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.28. The company had revenue of $0.50 million during the quarter, compared to the consensus estimate of $0.71 million. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. Sell-side analysts expect that SenesTech will post -10.22 earnings per share for the current fiscal year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Following Congress Stock Trades
- Can TikTok Stock Picks Really Make You Rich?
- Profitably Trade Stocks at 52-Week Highs
- The “Quality” Rotation: Back to Basics Investing
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.